MAPT and Alzheimer disease: These results might be explained by the previous and present finding that PPM1B dephosphorylates pDYRK1A at S258 and downregulates DYRK1A kinase activity, consequently decreasing the toxic modification of two AD-pathogenic proteins, such as tau and APP (23).